Pharma Equity Group A/S (CHIX:PEGC) Current Deferred Taxes Liabilities : kr0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharma Equity Group A/S Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Pharma Equity Group A/S's current deferred tax liabilities for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Pharma Equity Group A/S Current Deferred Taxes Liabilities Historical Data

The historical data trend for Pharma Equity Group A/S's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Current Deferred Taxes Liabilities Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Pharma Equity Group A/S Quarterly Data
	Mar16	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Pharma Equity Group A/S Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (CHIX:PEGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (CHIX:PEGc) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

PEG:Denmark

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.

Pharma Equity Group A/S (CHIX:PEGC) Headlines

No Headlines